Skip to content

CEREPHARMA

Active
Public limited companyfounded 2011active for 15 yearsRue des Journaliers(GHI) 15, 7822 Ath, BelgiumKBO/BCE: BE 0834.075.086

Acts, filings and financial milestones

Deadline for the 2026 accounts: 30-04-2027
2026
27-08
NBB filing Annual accounts 2025 filedNBB
full format
26-04
NBB filing Annual accounts 2025 filedPDF
abbreviated format · 4 days before the deadline
2025
28-04
NBB filing Annual accounts 2024 filedPDF
micro format · 2 days before the deadline
2024
26-04
NBB filing Annual accounts 2023 filedPDF
micro format · 4 days before the deadline
2023
28-12
Gazette deed 3 directors appointed, 1 director resigning, 2 reappointed
Resignation: CAMBIER Jacques,Marie,Louis,Emerence (director) · Reappointments: CAMBIER Bernard,Alfons,Lucie,Benoit (director) and DE WULF Anne-Sophie,Cecile,Marie,Luce (director) · Appointments: CAMBIER Florence, CAMBIER Bernard,Alfons,Lucie,Benoit and DE WULF Anne-Sophie,Cecile,Marie,Luce11 points ▸
  • General meeting, 12-12-2023
  • Amendment of the articles, mentioned 2 times in the deed
  • Capital, €765,000
  • Director resignation, CAMBIER Jacques,Marie,Louis,Emerence (director)
  • Director reappointment, CAMBIER Bernard,Alfons,Lucie,Benoit (director (not named in the articles))
  • Director reappointment, DE WULF Anne-Sophie,Cecile,Marie,Luce (director (not named in the articles))
  • Director appointment, CAMBIER Florence (director (not named in the articles))
  • Board meeting, “nomination administrateurs délégués”, 6 (deed in French)
  • Director appointment, CAMBIER Bernard,Alfons,Lucie,Benoit (managing director)
  • Director appointment, DE WULF Anne-Sophie,Cecile,Marie,Luce (managing director)
  • Registered office clause, “7822 Ghislenghien,Rue des Journaliers 15” (deed in French)

Open the act in the Belgian Official Gazette

28-04
NBB filing Annual accounts 2022 filedPDF
micro format · 2 days before the deadline
2022
30-09
Financial Back to profitnet €129,784
The net result is €129,784, after one loss-making year.
30-09
Financial Equity above €500,000equity €609,681 ▲27%
Equity rises from €479,897 to €609,681.
29-04
NBB filing Annual accounts 2021 filedPDF
micro format · 1 day before the deadline
2021
29-04
NBB filing Annual accounts 2020 filedPDF
micro format · 1 day before the deadline
2020
01-10
NBB filing Annual accounts 2019 filedPDF
micro format · 154 days late
30-09
Financial Back to profitnet €283,979
The net result is €283,979, after one loss-making year.
Show earlier events
2019
23-05
NBB filing Annual accounts 2018 filedPDF
micro format · 23 days late
2018
27-02
NBB filing Annual accounts 2017 filedPDF
micro format · 62 days before the deadline
2011
09-03
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

CEREPHARMA was incorporated on 25 February 2011.1 Total assets rose from €1.2m in 2019 to €1.5m in 2025 and headcount from 4.7 to 6.3 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Next steps